[go: up one dir, main page]

DE69728392D1 - Indolderivate verwendbar als endothelinrezeptorantagonisten - Google Patents

Indolderivate verwendbar als endothelinrezeptorantagonisten

Info

Publication number
DE69728392D1
DE69728392D1 DE69728392T DE69728392T DE69728392D1 DE 69728392 D1 DE69728392 D1 DE 69728392D1 DE 69728392 T DE69728392 T DE 69728392T DE 69728392 T DE69728392 T DE 69728392T DE 69728392 D1 DE69728392 D1 DE 69728392D1
Authority
DE
Germany
Prior art keywords
receptor antagonists
derivatives used
endotheline
indolder derivatives
indolder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728392T
Other languages
English (en)
Other versions
DE69728392T2 (de
Inventor
James Rawson
Neil Dack
Peter Dickinson
Kim James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE69728392D1 publication Critical patent/DE69728392D1/de
Publication of DE69728392T2 publication Critical patent/DE69728392T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DE1997628392 1996-05-09 1997-04-11 Indolderivate verwendbar als endothelinrezeptorantagonisten Expired - Fee Related DE69728392T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy
GB9609641 1996-05-09
PCT/EP1997/001882 WO1997043260A1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Publications (2)

Publication Number Publication Date
DE69728392D1 true DE69728392D1 (de) 2004-05-06
DE69728392T2 DE69728392T2 (de) 2005-01-13

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1997628392 Expired - Fee Related DE69728392T2 (de) 1996-05-09 1997-04-11 Indolderivate verwendbar als endothelinrezeptorantagonisten

Country Status (42)

Country Link
US (4) US6017945A (de)
EP (1) EP0901470B1 (de)
JP (1) JP3245179B2 (de)
KR (1) KR100331217B1 (de)
CN (1) CN1124262C (de)
AP (1) AP830A (de)
AR (1) AR007030A1 (de)
AT (1) ATE263151T1 (de)
AU (1) AU717849B2 (de)
BG (1) BG102873A (de)
BR (1) BR9709072A (de)
CA (1) CA2253876A1 (de)
CO (1) CO4650036A1 (de)
CZ (1) CZ292928B6 (de)
DE (1) DE69728392T2 (de)
DK (1) DK0901470T3 (de)
DZ (1) DZ2227A1 (de)
EA (1) EA001471B1 (de)
ES (1) ES2218675T3 (de)
GB (1) GB9609641D0 (de)
HN (1) HN1997000058A (de)
HR (1) HRP970249B1 (de)
HU (1) HUP9901245A3 (de)
ID (1) ID16878A (de)
IL (1) IL125903A0 (de)
IS (1) IS1856B (de)
MA (1) MA26428A1 (de)
NO (1) NO312547B1 (de)
NZ (1) NZ332640A (de)
OA (1) OA10896A (de)
PE (1) PE65098A1 (de)
PL (1) PL329725A1 (de)
PT (1) PT901470E (de)
SI (1) SI0901470T1 (de)
SK (1) SK150398A3 (de)
TN (1) TNSN97078A1 (de)
TR (1) TR199802269T2 (de)
TW (1) TW491838B (de)
UA (1) UA50767C2 (de)
UY (1) UY24546A1 (de)
WO (1) WO1997043260A1 (de)
ZA (1) ZA973963B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
HK1041212B (en) 1999-02-10 2005-12-02 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
WO2003000253A1 (en) 2001-06-20 2003-01-03 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
ATE331709T1 (de) 2002-12-10 2006-07-15 Wyeth Corp Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren
DE60306547T2 (de) 2002-12-10 2007-06-28 Wyeth Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen-aktivator
ATE411288T1 (de) 2002-12-10 2008-10-15 Wyeth Corp Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ATE430731T1 (de) 2002-12-10 2009-05-15 Wyeth Corp Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
WO2004067529A1 (en) * 2003-01-22 2004-08-12 Eli Lilly And Company Indole-derivative modulators of steroid hormone nuclear receptors
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
JP2008510816A (ja) 2004-08-23 2008-04-10 ワイス チアゾロ−ナフチル酸
CA2577782A1 (en) 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as pai-1 inhibitors
RU2007106868A (ru) 2004-08-23 2008-09-27 Вайет (Us) Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний
MX2008002117A (es) 2005-08-17 2008-09-26 Wyeth Corp Indoles sustituidos y metodos de uso de estos.
AU2007237874A1 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
US12343337B2 (en) 2016-09-29 2025-07-01 The Regents Of The University Of California Compounds for increasing neural plasticity
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
EP3931189A4 (de) 2019-02-27 2022-11-30 The Regents Of The University Of California Azepino-indole und andere heterocyclen zur behandlung von hirnerkrankungen
EP4448531A1 (de) 2021-12-15 2024-10-23 Delix Therapeutics, Inc. Phenoxy- und benzyloxy-substituierte psychoplastogene und verwendungen davon
CN117263832A (zh) * 2023-08-18 2023-12-22 辽宁龙田化工科技有限公司 一种2-氯-4-甲磺酰基苯甲酸合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637354A (de) * 1962-09-14
GB1255518A (en) * 1968-10-08 1971-12-01 Sumitomo Chemical Co 2-indolylacetic acid derivatives and process for production thereof
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
DE69118388T2 (de) 1990-09-10 1996-11-14 Rhone Poulenc Rorer Int Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
ATE189217T1 (de) * 1993-03-19 2000-02-15 Merck & Co Inc Phenoxyphenylessigsäurederivate
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
AU2697897A (en) 1997-12-05
ES2218675T3 (es) 2004-11-16
HUP9901245A3 (en) 2002-01-28
AP830A (en) 2000-05-03
NO985225L (no) 1998-11-09
NO312547B1 (no) 2002-05-27
DE69728392T2 (de) 2005-01-13
IS1856B (is) 2003-02-21
HN1997000058A (es) 1997-06-26
GB9609641D0 (en) 1996-07-10
JPH11508285A (ja) 1999-07-21
CN1216531A (zh) 1999-05-12
HK1019149A1 (en) 2000-01-14
AU717849B2 (en) 2000-04-06
JP3245179B2 (ja) 2002-01-07
CA2253876A1 (en) 1997-11-20
ID16878A (id) 1997-11-20
CO4650036A1 (es) 1998-09-03
TR199802269T2 (xx) 2001-12-21
ZA973963B (en) 1998-11-09
TW491838B (en) 2002-06-21
EP0901470B1 (de) 2004-03-31
IL125903A0 (en) 1999-04-11
US6384070B2 (en) 2002-05-07
TNSN97078A1 (fr) 2005-03-15
BG102873A (en) 1999-11-30
BR9709072A (pt) 1999-08-03
HRP970249B1 (en) 2003-06-30
SK150398A3 (en) 1999-03-12
DZ2227A1 (fr) 2002-12-25
CZ358298A3 (cs) 1999-08-11
AR007030A1 (es) 1999-10-13
US6306852B1 (en) 2001-10-23
AP9700982A0 (en) 1997-07-31
ATE263151T1 (de) 2004-04-15
US6017945A (en) 2000-01-25
US20010014677A1 (en) 2001-08-16
OA10896A (en) 2001-10-11
HUP9901245A2 (hu) 1999-08-30
PT901470E (pt) 2004-07-30
PE65098A1 (es) 1998-10-29
UY24546A1 (es) 2000-09-29
UA50767C2 (uk) 2002-11-15
WO1997043260A1 (en) 1997-11-20
IS4838A (is) 1998-08-28
SI0901470T1 (en) 2004-08-31
PL329725A1 (en) 1999-04-12
EA001471B1 (ru) 2001-04-23
EA199800908A1 (ru) 1999-06-24
KR20000010879A (ko) 2000-02-25
EP0901470A1 (de) 1999-03-17
NZ332640A (en) 2001-03-30
DK0901470T3 (da) 2004-07-12
CZ292928B6 (cs) 2004-01-14
CN1124262C (zh) 2003-10-15
HRP970249A2 (en) 1998-06-30
KR100331217B1 (ko) 2002-05-09
MA26428A1 (fr) 2004-12-20
US6136843A (en) 2000-10-24
NO985225D0 (no) 1998-11-09

Similar Documents

Publication Publication Date Title
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
FI970107A7 (fi) Heterosyklisiä takykiniinireseptoriantagonisteja
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
DE69232072D1 (de) Endothelin-rezeptor-antagonisten
ATE246677T1 (de) Chinolinderivate als tachykinin nk3 rezeptor antagonisten
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
NO986110D0 (no) IL-8 reseptor-antagonister
NO986109D0 (no) IL-8 reseptor-antagonister
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO990668L (no) IL-8 reseptor antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
BR9707733A (pt) Antagonistas de receptores muscarinicos oxa-e-tia-diazol
ID24162A (id) Antagonis-antagonis reseptor vitronektin
EP0929218A4 (de) R2y rezeptor antagonisten
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
EP1023068A4 (de) ALPHA 1a ADRENOREZEPTOR-ANTAGONISTEN
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69616364D1 (de) Endothelinrezeptorantagonisten
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
ATE206421T1 (de) Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee